[PHARMA] YoY Annualized Quarter Result on 30-Jun-2007 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Aug-2007
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2007
Quarter
30-Jun-2007 [#2]
Profit Trend
QoQ- 4.7%
YoY- 16.22%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Revenue 1,335,790 1,293,856 1,326,230 1,112,932 1,003,774 941,312 739,898 10.34%
PBT 65,516 89,042 96,924 44,822 34,354 65,122 73,866 -1.97%
Tax -17,862 -22,610 -32,046 -17,402 -10,728 -22,940 -27,334 -6.84%
NP 47,654 66,432 64,878 27,420 23,626 42,182 46,532 0.39%
-
NP to SH 48,108 64,438 63,304 25,418 21,870 38,820 46,532 0.55%
-
Tax Rate 27.26% 25.39% 33.06% 38.82% 31.23% 35.23% 37.00% -
Total Cost 1,288,136 1,227,424 1,261,352 1,085,512 980,148 899,130 693,366 10.86%
-
Net Worth 417,306 400,063 362,623 314,515 316,549 256,416 240,230 9.63%
Dividend
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Div 100,581 57,763 38,508 32,093 24,596 21,453 9,084 49.26%
Div Payout % 209.07% 89.64% 60.83% 126.26% 112.47% 55.26% 19.52% -
Equity
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Net Worth 417,306 400,063 362,623 314,515 316,549 256,416 240,230 9.63%
NOSH 107,001 106,968 106,968 106,978 106,942 102,157 100,937 0.97%
Ratio Analysis
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
NP Margin 3.57% 5.13% 4.89% 2.46% 2.35% 4.48% 6.29% -
ROE 11.53% 16.11% 17.46% 8.08% 6.91% 15.14% 19.37% -
Per Share
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
RPS 1,248.38 1,209.56 1,239.83 1,040.34 938.61 921.43 733.03 9.27%
EPS 44.96 60.24 59.18 23.76 20.44 38.00 46.10 -0.41%
DPS 94.00 54.00 36.00 30.00 23.00 21.00 9.00 47.82%
NAPS 3.90 3.74 3.39 2.94 2.96 2.51 2.38 8.57%
Adjusted Per Share Value based on latest NOSH - 106,924
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
RPS 92.68 89.77 92.02 77.22 69.65 65.31 51.34 10.34%
EPS 3.34 4.47 4.39 1.76 1.52 2.69 3.23 0.55%
DPS 6.98 4.01 2.67 2.23 1.71 1.49 0.63 49.28%
NAPS 0.2895 0.2776 0.2516 0.2182 0.2196 0.1779 0.1667 9.63%
Price Multiplier on Financial Quarter End Date
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Date 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 30/06/05 30/06/04 -
Price 4.98 3.80 3.27 3.53 4.51 4.53 4.82 -
P/RPS 0.40 0.31 0.26 0.34 0.48 0.49 0.66 -8.00%
P/EPS 11.08 6.31 5.53 14.86 22.05 11.92 10.46 0.96%
EY 9.03 15.85 18.10 6.73 4.53 8.39 9.56 -0.94%
DY 18.88 14.21 11.01 8.50 5.10 4.64 1.87 46.98%
P/NAPS 1.28 1.02 0.96 1.20 1.52 1.80 2.03 -7.39%
Price Multiplier on Announcement Date
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Date 11/08/10 21/08/09 14/08/08 17/08/07 16/08/06 18/08/05 06/08/04 -
Price 4.95 4.00 3.44 3.44 4.00 5.00 4.64 -
P/RPS 0.40 0.33 0.28 0.33 0.43 0.54 0.63 -7.28%
P/EPS 11.01 6.64 5.81 14.48 19.56 13.16 10.07 1.49%
EY 9.08 15.06 17.20 6.91 5.11 7.60 9.94 -1.49%
DY 18.99 13.50 10.47 8.72 5.75 4.20 1.94 46.23%
P/NAPS 1.27 1.07 1.01 1.17 1.35 1.99 1.95 -6.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment